Trial intelligence / Profile preview

Phase II trial of intranasal midazolam via MAD for pediatric painful procedures

2009-013107-56Phase 2Completed

Sponsor
Policlinico Gemelli
Start
Aug 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of midazolam in procedural pain, sponsored by Policlinico Gemelli. Primary endpoints: Wong-Baker scale and Ramsay scale. Started Aug 2009; status: completed.

02

Drugs

midazolam
03

Conditions

procedural pain

Beyond the preview

Go deeper on 2009-013107-56.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-013107-56.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call